[{"Assets_0_Q3_USD":167838000000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":11089000000.0,"NetIncomeLoss_1_Q3_USD":4114000000.0,"NetIncomeLoss_3_Q3_USD":11546000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":5986000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":5998000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":5875000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":5899000000.0,"StockholdersEquity_0_Q3_USD":71319000000.0,"EarningsPerShareBasic_1_Q3_USD":0.7,"EarningsPerShareBasic_3_Q3_USD":1.96,"EarningsPerShareDiluted_1_Q3_USD":0.69,"EarningsPerShareDiluted_3_Q3_USD":1.92,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":13298000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":39670000000.0,"Ticker":"PFE","CIK":"78003","name":"PFIZER INC","OfficialName":"Pfizer Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"283405322403.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20181108"}]